Cargando…

Validation of the brief international cognitive assessment for multiple sclerosis (BICAMS) in the Portuguese population with multiple sclerosis

BACKGROUND: The validation of international cognitive batteries in different multiple sclerosis (MS) populations is essential. Our objective was to obtain normative data for the Portuguese population of the Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS) and assess its relia...

Descripción completa

Detalles Bibliográficos
Autores principales: Sousa, Cláudia, Rigueiro-Neves, Mariana, Miranda, Telma, Alegria, Paulo, Vale, José, Passos, Ana Margarida, Langdon, Dawn, Sá, Maria José
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6192303/
https://www.ncbi.nlm.nih.gov/pubmed/30332999
http://dx.doi.org/10.1186/s12883-018-1175-4
_version_ 1783363882562093056
author Sousa, Cláudia
Rigueiro-Neves, Mariana
Miranda, Telma
Alegria, Paulo
Vale, José
Passos, Ana Margarida
Langdon, Dawn
Sá, Maria José
author_facet Sousa, Cláudia
Rigueiro-Neves, Mariana
Miranda, Telma
Alegria, Paulo
Vale, José
Passos, Ana Margarida
Langdon, Dawn
Sá, Maria José
author_sort Sousa, Cláudia
collection PubMed
description BACKGROUND: The validation of international cognitive batteries in different multiple sclerosis (MS) populations is essential. Our objective was to obtain normative data for the Portuguese population of the Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS) and assess its reliability. METHODS: The BICAMS was applied to 105 MS patients and 60 age, gender and education matched healthy controls (HC). In order to test its reliability, BICAMS was re-administered in a subset of 25 patients after a 7-month interval. RESULTS: Most participants were women, with a mean age of 37, 21 years and a mean of 14,08 years of education. The vast majority of the MS patients (92.4%) had the relapsing remitting type, 58.1% were professionally active, mean disease duration was 6.52 years, median EDSS score was 1.5 (range: 0–6.0) and the median MSSS score was 2.01 (IQR range: 3.83). The MS group presented significantly higher scores of anxiety and depression than HC and 47,4% had fatigue. The MS group performed significantly worse than the control group across the three neuropsychological tests, yielding the following values: SDMT: t(165) = 3.77, p = .000; CVLT-II: t(165) = 2.98, p = .003; and BVMT-R: t(165) = 2.94, p = .004. The mean raw scores for Portuguese normative data were as follows: SDMT: 58.68 ± 10.02; CVLT-II: 60.47 ± 10.12; and BVMT-R: 24.68 ± 5.52. Finally, test–retest reliability coefficients for each test were as follows: SDMT: r = .90; CVLT-II: r = .71; and BVMT-R: r = .84. CONCLUSIONS: The Portuguese version of BICAMS here in described is a reliable monitoring instrument for identifying MS patients with cognitive impairment.
format Online
Article
Text
id pubmed-6192303
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-61923032018-10-22 Validation of the brief international cognitive assessment for multiple sclerosis (BICAMS) in the Portuguese population with multiple sclerosis Sousa, Cláudia Rigueiro-Neves, Mariana Miranda, Telma Alegria, Paulo Vale, José Passos, Ana Margarida Langdon, Dawn Sá, Maria José BMC Neurol Research Article BACKGROUND: The validation of international cognitive batteries in different multiple sclerosis (MS) populations is essential. Our objective was to obtain normative data for the Portuguese population of the Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS) and assess its reliability. METHODS: The BICAMS was applied to 105 MS patients and 60 age, gender and education matched healthy controls (HC). In order to test its reliability, BICAMS was re-administered in a subset of 25 patients after a 7-month interval. RESULTS: Most participants were women, with a mean age of 37, 21 years and a mean of 14,08 years of education. The vast majority of the MS patients (92.4%) had the relapsing remitting type, 58.1% were professionally active, mean disease duration was 6.52 years, median EDSS score was 1.5 (range: 0–6.0) and the median MSSS score was 2.01 (IQR range: 3.83). The MS group presented significantly higher scores of anxiety and depression than HC and 47,4% had fatigue. The MS group performed significantly worse than the control group across the three neuropsychological tests, yielding the following values: SDMT: t(165) = 3.77, p = .000; CVLT-II: t(165) = 2.98, p = .003; and BVMT-R: t(165) = 2.94, p = .004. The mean raw scores for Portuguese normative data were as follows: SDMT: 58.68 ± 10.02; CVLT-II: 60.47 ± 10.12; and BVMT-R: 24.68 ± 5.52. Finally, test–retest reliability coefficients for each test were as follows: SDMT: r = .90; CVLT-II: r = .71; and BVMT-R: r = .84. CONCLUSIONS: The Portuguese version of BICAMS here in described is a reliable monitoring instrument for identifying MS patients with cognitive impairment. BioMed Central 2018-10-17 /pmc/articles/PMC6192303/ /pubmed/30332999 http://dx.doi.org/10.1186/s12883-018-1175-4 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Sousa, Cláudia
Rigueiro-Neves, Mariana
Miranda, Telma
Alegria, Paulo
Vale, José
Passos, Ana Margarida
Langdon, Dawn
Sá, Maria José
Validation of the brief international cognitive assessment for multiple sclerosis (BICAMS) in the Portuguese population with multiple sclerosis
title Validation of the brief international cognitive assessment for multiple sclerosis (BICAMS) in the Portuguese population with multiple sclerosis
title_full Validation of the brief international cognitive assessment for multiple sclerosis (BICAMS) in the Portuguese population with multiple sclerosis
title_fullStr Validation of the brief international cognitive assessment for multiple sclerosis (BICAMS) in the Portuguese population with multiple sclerosis
title_full_unstemmed Validation of the brief international cognitive assessment for multiple sclerosis (BICAMS) in the Portuguese population with multiple sclerosis
title_short Validation of the brief international cognitive assessment for multiple sclerosis (BICAMS) in the Portuguese population with multiple sclerosis
title_sort validation of the brief international cognitive assessment for multiple sclerosis (bicams) in the portuguese population with multiple sclerosis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6192303/
https://www.ncbi.nlm.nih.gov/pubmed/30332999
http://dx.doi.org/10.1186/s12883-018-1175-4
work_keys_str_mv AT sousaclaudia validationofthebriefinternationalcognitiveassessmentformultiplesclerosisbicamsintheportuguesepopulationwithmultiplesclerosis
AT rigueironevesmariana validationofthebriefinternationalcognitiveassessmentformultiplesclerosisbicamsintheportuguesepopulationwithmultiplesclerosis
AT mirandatelma validationofthebriefinternationalcognitiveassessmentformultiplesclerosisbicamsintheportuguesepopulationwithmultiplesclerosis
AT alegriapaulo validationofthebriefinternationalcognitiveassessmentformultiplesclerosisbicamsintheportuguesepopulationwithmultiplesclerosis
AT valejose validationofthebriefinternationalcognitiveassessmentformultiplesclerosisbicamsintheportuguesepopulationwithmultiplesclerosis
AT passosanamargarida validationofthebriefinternationalcognitiveassessmentformultiplesclerosisbicamsintheportuguesepopulationwithmultiplesclerosis
AT langdondawn validationofthebriefinternationalcognitiveassessmentformultiplesclerosisbicamsintheportuguesepopulationwithmultiplesclerosis
AT samariajose validationofthebriefinternationalcognitiveassessmentformultiplesclerosisbicamsintheportuguesepopulationwithmultiplesclerosis